Cutting-edge industrial plant

our Manufacturing site

State-of-the-art facility

from lab to industrial scale

Thanks to our teams and state-of-the-art equipment, our company can produce a wide range of probiotics and postbiotics tailored to specific requirements and deliver high-quality services to our clients.

R&D laboratorySpecialist team in microbiology, focusing on the optimization of your probiotics/ postbiotics and next-generation strains. Expertise in molecular biology and capabilities in genome and genetic characterization.

A factory Equipped with large-scale fermenters and high-performance freeze-drying devices, with the ability to apply designed and optimized efficient production processes and stabilize bioproducts.

Bioprox Healthcare’s pilot facility is crucial for the successful transition of new production processes and technologies from laboratory to commercial scale. Both our R&D and production teams collaborate for a seamless transition.

End-to-end development

for bacterial production

Bioprox’s services encompass the entire production process, ensuring high-quality outcomes at every stage:

Fermentation using high-capacity and cutting-edge fermenters to cultivate microorganisms under optimal conditions

Separation of biomass by centrifugation or ultrafiltration

High-performance drying step

Grinding under controlled atmosphere with relative humidity and at different granulometries

Blending

single or multi-strains blends with excipients

Interested by CDMO services ?

highly-skilled team.

Processes managed by highly-skilled engineers and technicians

"With my colleagues, engineers and technicians, we leverage our scientific and technical expertise to develop innovative solutions. With decades of experience in scaling up and industrial operation, we transform laboratory processes into viable industrial processes at our biotechnology plant”.

Quentin, industrial fermentation technician – Bioprox

discover our team

Flourishing growth.

upgrading of the manufacturing site since 1975

To support Bioprox's growth, a major expansion of its production site is underway from 2023. By doubling its industrial capacities, the French company will significantly strengthen its position in both national and international markets. This is the third major expansion the plant has undergone since its foundation in 1975.

equipments’ history.

Zoom on state-of-the-art bioreactors and equipments

1975

1985

1998

2003

2009

2011

2016

2019

2021

2023

1975
Acquisition of the Noyant dairy factory
and its conversion into an industrial site, modernising and transferring the Bioprox factory from Fourcarmont (Normandy) to Noyant.

1985
Construction of the fermentation and freeze-drying workshop
producing lactic acid bacteria, ripening cultures, and oenological yeasts.

1998
Initiation of export.

2003
First significant increase
in production capacities to meet growing demands.

2009
Relocation of the R&D centre
from Château-Renault to the Noyant site to enhance industrial transfer activities.

2011
New business unit dedicated to probiotics

2016
Creation of an industrial workshop within the factory
for the new activity of soil microorganism biosolutions with Cybèle Agrocare.

2019
Second expansion of the manufacturing site
with an increase of the R&D centre to 1000 m².

2021
Obtaining FSSC 22000 certification & Ecovadis silver medal.

2023
Third modernisation and investment in new technologies
Launch of two major projects to advance the Bioprox production facility. This strategic expansion involves not only increasing industrial fermentation capacities twofold but also a profound transformation of production processes through the integration of the latest technologies.

"The manufacturing site in Noyant is currently undergoing significant expansion.""This initiative is pivotal as we aim to support the average annual growth of 30% witnessed over the past decade. Indeed, the modernisation not only enhances our operational robustness but also underscores our commitment to meeting the growing demand and requirements to a “T”. Bioprox Healthcare has always been able to rely on knowledge of industrial processes and the properties of cultivated microorganisms. We do have this level of technicity thanks to our sister company, Bioprox Cultures, a French specialist in large-scale industrial fermentation since 1975. The company has developed a solid industrial production activity for over 50 bacterial species as well as high-quality consulting services. This expertise is fundamental to enhancing the effectiveness of probiotics in our clients' future products, solidifying Bioprox's position in the competitive landscape of probiotics’ sector."

Eric De Mol, Bioprox Healthcare’s General Manager — January 2024

Our certifications

Ensuring the best quality to our customers

We maintain high-quality processes in our operations, adhere to current regulatory standards and foster a culture of quality compliance.

Corporate Social Responsibility (CSR) is important to us. Bioprox Healthcare has been awarded the Ecovadis Silver certification. We strive to integrate social and environmental concerns into all our activities.

Certified ISO 9001 manufacturing site
Certified FSSC 22000 manufacturing site
Halal & Kosher productions
Allergen free  
l Non-GMO

Our R&D centreOur CDMO services

Interested by our services ?

contact us
Update cookies preferences